Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs.
Qiao L, Hu S, Huang K, Su T, Li Z, Vandergriff A, Cores J, Dinh PU, Allen T, Shen D, Liang H, Li Y, Cheng K. · 2020
Read Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs. by Qiao L, Hu S, Huang K, Su T, Li Z, Vandergriff A, Cores J, Dinh PU, Allen T, Shen D, Liang H, Li Y, Cheng K. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7069079.txt.
Description
Qiao and co-authors turn tumour exosomes into drug couriers in Theranostics. Cancer is the second leading cause of death worldwide, and patients need therapies that hit tumours with minimal collateral damage. Exosomes are nano-shuttles cells use to talk to each other. Tumour-derived exosomes carry a protein and lipid makeup much like their parent cells, which raised a question: do they also know the way home?
The team isolated exosomes from two cancer cell lines and tracked them in culture and in mice. Exosomes fused preferentially with their parent cancer cells, and injected ones homed to their original tumour tissue. Loaded with the chemotherapy drug Doxil, the engineered exosomes, called D-exo, targeted tumours and treated them better than the free drug. A proteome array pointed to the surface molecules guiding the homing. The authors cast the vesicles as Trojan horses built by the tumour itself.
Catalog record
| CREATOR | Qiao L, Hu S, Huang K, Su T, Li Z, Vandergriff A, Cores J, Dinh PU, Allen T, Shen D, Liang H, Li Y, Cheng K. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |